Krystal Biotech, Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Christopher L. JacobsHouse · R · NY |
KRYSKrystal Biotech, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jan 20, 2023 | Dec 12, 2022 | Filing ↗ |
Whale Activity
- Increased176
- New73
- Held57
- Decreased118
- Closed48
- No prior filing19
| Filer | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 4.4M | $1.48B | increased |
| BlackRock, Inc. | 3.6M | $1.19B | decreased |
| Avoro Capital Advisors LLC | 2.9M | $960.7M | held |
| STATE STREET CORP | 1.4M | $472.3M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $428.0M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $398.0M | decreased |
| Soleus Capital Management, L.P. | 1.1M | $379.0M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 811.7K | $270.0M | increased |
| Capital World Investors | 779.3K | $259.2M | increased |
| Hood River Capital Management LLC | 672.0K | $223.5M | increased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 586.4K | $195.0M | decreased |
| Redmile Group, LLC | 527.7K | $175.5M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −399 | $366.56 | $146K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −826 | $365.41 | $302K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −1,329 | $364.48 | $484K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −565 | $363.34 | $205K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −1,992 | $362.65 | $722K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −1,242 | $361.61 | $449K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −2,320 | $360.47 | $836K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −3,392 | $359.39 | $1.2M | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −3,180 | $358.42 | $1.1M | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −3,962 | $357.57 | $1.4M | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −3,267 | $356.37 | $1.2M | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −2,006 | $355.57 | $713K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan SumaPresident, R&D · Director · 10% owner | Sale | −520 | $354.54 | $184K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −405 | $366.56 | $148K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −847 | $365.42 | $310K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −1,358 | $364.48 | $495K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −573 | $363.34 | $208K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −2,010 | $362.65 | $729K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −1,214 | $361.61 | $439K | Sep 4, 2026 | Form 4 ↗ |
| Krishnan Krish SPresident and CEO · Director · 10% owner | Sale | −2,266 | $360.46 | $817K | Sep 4, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1.8M | $647.8M | 10.30% | Aug 31, 2026 |
| iShares Core S&P Small-Cap ETF iShares Trust | 1.6M | $587.4M | 0.53% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 889.5K | $330.6M | 0.01% | Jun 30, 2026 |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 816.1K | $293.3M | 0.30% | Aug 31, 2026 |
| SMALLCAP World Fund Inc | 752.2K | $279.6M | 0.30% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 670.9K | $249.3M | 0.30% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 642.5K | $238.8M | 0.13% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 370.5K | $137.7M | 0.29% | Jun 30, 2026 |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 329.8K | $122.6M | 1.84% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 318.7K | $118.5M | 1.10% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list KRYS's shares (CUSIP 501147102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
No lobbying filings found naming Krystal Biotech, Inc. as the client.
Government Contracts
No federal contract awards found for Krystal Biotech, Inc..
U.S. Patents
No USPTO patent applications found for Krystal Biotech, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $389.1M | $290.5M | $50.7M | $0 | $0 |
| Operating income | $161.3M | $65.7M | -$109.6M | -$145.2M | -$68.3M |
| Net income | $204.8M | $89.2M | $10.9M | -$140.0M | -$69.6M |
| Diluted EPS | $6.84 | $3.00 | $0.39 | -$5.49 | -$3.13 |
| Operating cash flow | $200.9M | $123.4M | -$88.8M | -$100.6M | -$47.9M |
| Cash and equivalents | $496.3M | $344.9M | $358.3M | $161.9M | $341.2M |
| Total assets | $1.33B | $1.06B | $818.4M | $558.5M | $626.3M |
| Total liabilities | $114.2M | $109.5M | $39.7M | $36.2M | $32.7M |
| Shareholders' equity | $1.22B | $946.4M | $778.6M | $522.2M | $593.6M |
As Krystal Biotech, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 17, 2026 ↗
Stock Splits
No stock splits in KRYS's price history.
Material Events (8-K)
- 8-K · Items 2.02, 9.01Results of operationsNov 2, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureOct 15, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 3, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 21, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 20, 2026
EDGAR ↗ - 8-K · Items 9.01May 4, 2026
EDGAR ↗

